Murine high specificity/sensitivity competitive europium insulin autoantibody assay

Diabetes Technology and Therapeutics

Volumn 11, Issue 4, 2009, Pages 227-233

  Babaya, Naru ^a   Liu, Edwin ^a   Miao, Dongmei ^a   Li, Marcella ^a   Yu, Liping ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AVIDIN; B9-23 PEPTIDE; EUROPIUM; INSULIN; INSULIN ANTIBODY; INSULIN DERIVATIVE; INSULIN I 125; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANALYSIS; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; BIOTINYLATION; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPIUM; HUMANS; INSULIN; INSULIN ANTIBODIES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; SENSITIVITY AND SPECIFICITY; STREPTAVIDIN;

EID: 64349121512     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0072     Document Type: Article

References (20)

1. Wilkin T, Palmer J, Kurtz A, Bonifacio E, Diaz JL: The second International Workshop on the Standardisation of Insulin Autoantibody (IAA) measurement. Held in New York, 27-30 October 1987. Diabetologia 1988;31:449-450.
2. Kuglin B, Kolb H, Greenbaum C, Maclaren NK, Lernmark A, Palmer JP: The Fourth International Workshop on the Standardisation of Insulin Autoantibody Workshop. Diabe-tologia 1990;33:638-639.
3. Bingley PJ, Bonifacio E, Mueller PW: Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 2003;52:1128-1136.
4. Yu L, Eisenbarth G, Bonifacio E, Thomas J, Atkinson M, Wasserfall C: The second murine autoantibody workshop: remarkable interlaboratory concordance for radiobinding assays to identify insulin autoantibodies in nonobese diabetic mice. Ann N Y Acad Sci 2003;1005:1-12.
5. Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E, Singh B: International Workshop on Lessons from Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 2001;50:2451-2458.
6. Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E, Singh B: International Workshop on Lessons from Animal Models for Human Type 1 Diabetes: analyzing target autoantigens of humoral immunity in nonobese diabetic mice. Ann N Y Acad Sci 2002;958:1-2.
7. Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA: A novel micro-assay for insulin autoantibodies. J Autoimmun 1997;10:473-478.
8. Yu L, Robles DT, Abiru N, Kaur P, Rewers M, Kelemen K, Eisenbarth GS: Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A 2000;97:1701-1706.
9. Greenbaum CJ, Palmer JP, Kuglin B, Kolb H: Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement. J Clin Endocrinol Metab 1992;74:1040-1044.
10. Ankelo M, Westerlund-Karlsson A, Ilonen J, Knip M, Savola K, Kankaanpaa P, Merio L, Siitari H, Hinkkanen A: Time-resolved fluorometric assay for detection of autoantibodies to glutamic acid decarboxylase (GAD65). Clin Chem 2003; 49:908-915.
11. Westerlund-Karlsson A,Suonpaa K, Ankelo M,Ilonen J, Knip M, Hinkkanen AE: Detection of autoantibodies to protein tyrosine phosphatase-like protein IA-2 with a novel time-resolved fluorimetric assay. Clin Chem 2003;49:916-923.
12. Koczwara K, Schenker M, Schmid S, Kredel K, Ziegler AG, Bonifacio E: Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse. Clin Immunol 2003;106:155-162.
13. Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS: Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005;435: 220-223.
14. Jaeckel E, Lipes MA, von Boehmer H: Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat Immunol 2004;5:1028-1035.
15. Thebault-Baumont K, Dubois-Laforgue D, Krief P, Briand JP, Halbout P, Vallon-Geoffroy K, Morin J, Laloux V, Lehuen A, Carel JC, Jami J, Muller S, Boitard C: Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest 2003;111:851-857.
16. French MB, Allison J, Cram DS, Thomas HE, Dempsey-Collier M, Silva A, Georgiou HM, Kay TW, Harrison LC, Lew AM: Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 1997; 46:34-39.
17. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E: Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 2004;114:589-597.
18. Pugliese A: The insulin gene in type 1 diabetes. IUBMB Life 2005;57:463-468.
19. Zhang L, Barker JM, Babu S, Su M, Stenerson M, Cheng M, Shum A, Zamir E, Badolato R, Law A, Eisenbarth GS, Anderson MS: A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1. Clin Immunol 2007;125:131-137.
20. Castano L, Ziegler AG, Ziegler R, Shoelson S, Eisenbarth GS: Characterization of insulin autoantibodies in relatives of patients with type I diabetes. Diabetes 1993;42:1202-1209.